Skip to main content

MoneyWorks4Me

Kopran informs about board meeting

26 Oct 2023 Evaluate
Kopran has informed that the meeting of the Board of Directors of the Company is scheduled on 07/11/2023, to consider and approve Unaudited Standalone and Consolidated Financial Result of the Company for the Second quarter ended September 30, 2023.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1805.60
Dr. Reddys Labs. 1359.90
Cipla 1379.75
Lupin 2014.80
Zydus Lifesciences 1240.10
View more..